Market Research Logo

US Market Report for Binocular Indirect Ophthalmoscopes 2017 - MedCore

US Market Report for Binocular Indirect Ophthalmoscopes 2017 - MedCore

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
The market is expected to increase over the forecast period. With the ongoing development of new and innovative BIOs, the market is expected to experience moderate growth as physicians upgrade their devices. This will lead to a slight increase in unit sales. There were approximately 18,000 practicing ophthalmologists in the United States that year. Although there were fewer ophthalmologists than optometrists, each ophthalmologist had, on average, 3.5 lanes in their practice. Every lane requires a binocular indirect ophthalmoscope. As a result, the demand for BIOs is higher among ophthalmologists.

Binocular indirect ophthalmoscopes (BIOs) are used by all optometrists and ophthalmologists and are needed in every practice, as well as in every lane of a practice. In 2016, there were approximately 40,000 optometrists and 18,000 practicing ophthalmologists in the United States. Typically, the average optometrist has 1.5 lanes in their practice and the average ophthalmologist has 3.5 lanes.


EXECUTIVE SUMMARY
U.S. DIAGNOSTIC OPHTHALMIC DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1.1 Glaucoma
2.1.2 Diabetic Retinopathy
2.1.3 Refractive Error
2.1.4 Age-Related Macular Degeneration
2.1.5 Astigmatism
2.1.6 Cataract
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Binocular Indirect Ophthalmoscope
3.2 FDA RECALLS
3.2.1 Alcon
3.2.2 Abbott Medical Optics (AMO)
3.2.3 Topcon
3.2.4 Nidek
3.3 CLINICAL TRIALS
3.3.1 Alcon
3.3.2 Carl Zeiss Meditec
3.3.3 Topcon
BINOCULAR INDIRECT OPHTHALMOSCOPE MARKET
4.1 INTRODUCTION
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Total Binocular Indirect Ophthalmoscope Market
4.3.2 Optometry Binocular Indirect Ophthalmoscope Market
4.3.3 Ophthalmology Binocular Indirect Ophthalmoscope Market
4.3.4 Wired and Non-Wired Binocular Indirect Ophthalmoscopes
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Diagnostic Ophthalmic Device Market by Segment, U.S., 2013 – 2023
Chart 1 2: Diagnostic Ophthalmic Device Market Overview, U.S., 2013 & 2023
Chart 4 1: Binocular Indirect Ophthalmoscope Market by Segment, U.S., 2013 – 2023
Chart 4 2: Binocular Indirect Ophthalmoscope Market Breakdown, U.S., 2016
Chart 4 3: Binocular Indirect Ophthalmoscope Market Breakdown, U.S., 2023
Chart 4 4: Total Binocular Indirect Ophthalmoscope Market, U.S., 2013 – 2023
Chart 4 5: Optometry Binocular Indirect Ophthalmoscope Market, U.S., 2013 – 2023
Chart 4 6: Ophthalmology Binocular Indirect Ophthalmoscope Market, U.S., 2013 – 2023
Chart 4 7: Leading Competitors, Binocular Indirect Ophthalmoscope Market, U.S., 2016
List of Figures
Figure 1 1: Diagnostic Ophthalmic Device Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1 2: Diagnostic Ophthalmic Device Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Diagnostic Ophthalmic Device Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Diagnostic Ophthalmic Device Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Diagnsotic Ophthalmic Device Market, U.S., 2013 – 2016 (1 of 2)
Figure 1 7: Recent Events in the Diagnsotic Ophthalmic Device Market, U.S., 2013 – 2016 (2 of 2)
Figure 1 8: Diagnostic Ophthalmic Device Markets Covered, U.S., 2016 (1 of 2)
Figure 1 9: Diagnostic Ophthalmic Device Markets Covered, U.S., 2016 (2 of 2)
Figure 1 10: Key Report Updates
Figure 1 11: Version History
Figure 3 1: Binocular Indirect Ophthalmoscope Devices by Company
Figure 3 2: Class 2 Device Recall Alcon
Figure 3 3: Class 2 Device Recall Alcon
Figure 3 4: Class 2 Device Recall Alcon
Figure 3 5: Class 2 Device Recall Alcon
Figure 3 6: Class 2 Device Recall Alcon
Figure 3 7: Class 2 Device Recall Alcon
Figure 3 8: Class 2 Device Recall Alcon
Figure 3 9: Class 2 Device Recall Alcon
Figure 3 10: Class 2 Device Recall Abbott Medical Optics
Figure 3 11: Class 2 Device Recall Abbott Medical Optics
Figure 3 12: Class 2 Device Recall Abbott Medical Optics
Figure 3 13: Class 2 Device Recall Abbott Medical Optics
Figure 3 14: Class 2 Device Recall Abbott Medical Optics
Figure 3 15: Class 2 Device Recall Abbott Medical Optics
Figure 3 16: Class 2 Device Recall Abbott Medical Optics
Figure 3 17: Class 2 Device Recall Abbott Medical Optics
Figure 3 18: Class 2 Device Recall Abbott Medical Optics
Figure 3 19: Class 2 Device Recall Abbott Medical Optics
Figure 3 20: Class 2 Device Recall Topcon
Figure 3 21: Class 2 Device Recall Nidek
Figure 3 22: Class 2 Device Recall Nidek
Figure 3 23: Clinical Investigation of Corneal Incision Size After Intraocular Lens (IOL) Implantation
Figure 3 24: Clinical Outcomes Following Treatment With SYSTANE® BALANCE
Figure 3 25: Clinical Evaluation of DAILIES TOTAL 1® Performance in a Japanese Population
Figure 3 26: CLEAR CARE® PLUS for Presbyopic Contact Lens Wearers
Figure 3 27: Clinical Assessment of DAILIES TOTAL1® (DT1) Multifocal
Figure 3 28: Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
Figure 3 29: Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions
Figure 3 30: Glaucoma HFA / OCT Specificity Study
Figure 3 31: OCT Image Quality Performance Evaluation
Figure 3 32: Evaluation of the Signal to Noise Ratio at Various Retinal Layers
Figure 3 33: Slit Lamp Model SL-D-301 and DC-4 Digital Camera Attachment
Figure 4 1: Binocular Indirect Ophthalmoscope Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 4 2: Total Binocular Indirect Ophthalmoscope Market, U.S., 2013 – 2023
Figure 4 3: Optometry Binocular Indirect Ophthalmoscope Market, U.S., 2013 – 2023
Figure 4 4: Ophthalmology Binocular Indirect Ophthalmoscope Market, U.S., 2013 – 2023
Figure 4 5: Drivers and Limiters, Binocular Indirect Ophthalmoscope Market, U.S., 2016
Figure 4 6: Leading Competitors, Binocular Indirect Ophthalmoscope Market, U.S., 2016
Figure 6 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report